Cardiac Amyloid Biorepository
study id #: NCT05521503
condition: Cardiac Amyloidosis
status: Recruiting
purpose:Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by cardiac amyloidosis and therapeutic interventions.
results: https://clinicaltrials.gov/ct2/show/results/NCT05521503
last updated: February 22, 2024
-
Mazen Hanna, MDDr. Mazen Hanna is a cardiologist at the...
-
Pitfalls in Conducting Prospective Trials in Stage III Cardiac Amyloidosis – Experience from the REVEAL StudyVery few prospective clinical trials hav...
-
Hereditary Amyloidosis CanadaThe Hereditary Amyloidosis Canada (HAC) ...
-
Julia Platt, MS, LCGCJulia earned her MS in Genetic Counselin...
-
The Effect and Safety of Bortezomib in the Treatment of AL Amyloidosis: A Systematic Review and Meta-AnalysisBortezomib began to be used in the treat...
-
Introduction to Light Chain (AL) Amyloidosis Webinarhttps://www.youtube.com/watch?v=FBETo4zD...
-
Dysphagia Due to Macroglossia in a Patient With Amyloidosis Associated With Multiple Myeloma: A Case ReportAmyloidosis is a group of heterogeneou...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.